MONOVISC for Shoulder Joint Pain Relief Due to Osteoarthritis
A Prospective Study of a Single Injection Cross-linked Sodium Hyaluronate (MONOVISC) to Provide Symptomatic Relief of Osteoarthritis of Shoulder Joint
Sponsor: Anika Therapeutics, Inc.
Listed as NCT04204265, this NA trial focuses on Osteo Arthritis Shoulders and remains completed. Sponsored by Anika Therapeutics, Inc., it has been updated 8 times since 2019, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
8 versions recorded-
Sep 2025 — Present [monthly]
Completed NA
-
Feb 2025 — Sep 2025 [monthly]
Completed NA
-
Sep 2024 — Feb 2025 [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
May 2021 — Jul 2024 [monthly]
Completed NA
Status: Recruiting → Completed
▶ Show 3 earlier versions
-
Feb 2021 — May 2021 [monthly]
Recruiting NA
-
Jan 2021 — Feb 2021 [monthly]
Recruiting NA
-
Jan 2020 — Jan 2021 [monthly]
Recruiting NA
First recorded
Dec 2019
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Anika Therapeutics, Inc.
For direct contact, visit the study record on ClinicalTrials.gov .